← FDA DRUG APPROVALS

FDA NDA · NDA006213

PROPYLTHIOURACIL

Sponsor: LILLY

APPLICATION
NDA006213
TYPE
NDA
ORIGINAL APPROVAL
1947-07-29
LATEST ACTION
1990-02-05
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

PROPYLTHIOURACILDiscontinued
PROPYLTHIOURACIL 50MG · TABLET · ORAL

Approval history

1990-02-05Labeling · Supplement 17AP
1990-01-18Labeling · Supplement 18AP
1989-08-15Labeling · Supplement 15AP
1989-08-15Labeling · Supplement 16AP
1987-07-06Labeling · Supplement 14AP
1986-08-08Labeling · Supplement 13AP
1986-05-07Labeling · Supplement 12AP
1986-01-07Labeling · Supplement 11AP
1982-06-02Labeling · Supplement 10AP
1976-05-13Labeling · Supplement 6AP
1947-07-29UNKNOWN · Original · unknownAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →